Twenty years of FAB
Gestation through adolescence
Bibliographic Data
| ID | 15684227 |
|---|---|
| Authors | Helen Holmes (0000-0002-4918-2007, corresponding author) |
| Year | 2014 |
| Volume | 7 |
| Issue | 1 |
| Pages | 199-203 |
| Publication date | 2014-03-01 |
| Open Access | No |
| Type | ARTICLE |
| Venue | International Journal of Feminist Approaches to Bioethics (JOURNAL) |
| Journal identifiers | ISSN: 1937-4577 • E-ISSN: 1937-4585 |
| Publisher | University of Toronto Press Inc. (UTPress) (PUBLISHER) |
| DOI | 10.3138/ijfab.7.1.199 |
| OpenAlex | W2020864832 |
| Language | EN |
| References cited | 2 |
H did Anne Donchin and I (“Becky”) dream up, invent, or rather, conceive, FAB? It’s a strange story. We first met each other in 1984 in Sweden at a meeting of FINRET, a group soon to change its name to FINRRAGE (the Feminist International Network of Resistance to Reproductive and Genetic Engineering). Anne came experienced in philosophy and women’s studies; I came with degrees in biology and the experience of directing the EIRTAW conference in 1979 (Ethical Issues in Reproductive Technology: Analysis by Women). We shared many common interests and concerns: methods and policies that were rather wanting in ethics; development and expansion of the new reproductive technologies by men, even though women give birth; and, sadly missing, women’s analyses in every and all areas of bioethics. So we conceived—let’s call it—an embryo. Gestation lasted until birth in 1992, when we named it FAB (the International Network on Feminist Approaches to Bioethics). FAB in the nursery stage opened with an invitational letter: Anne sent it to feminist scholars whom she knew and to many women who had attended my EIRTAW conference. The vision in our letter was “to develop a more inclusive theory of bioethics encompassing the experiences of
Bioethics · Dream · Political science · Pregnancy · Reproductive health · Reproductive rights · Reproductive technology · Sociology · Demography · Gender Studies · Law · Psychology · Reproductive Health and Technologies
| Highly cited | No |
|---|